Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Novotná

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Klinicka Mikrobiologie a Infekcni Lekarstvi|October 2, 2022
[Pneumothorax, pneumomediastinum and subcutaneous emphysema as complica-tions of COVID-19]Tereza Koníčková, František Puškáš, Eva Novotná, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 17, 2013
Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyaseMartin Krátký, Jarmila Vinšová, Eva Novotná, et al.
Ceska a Slovenska Farmacie : Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti|February 8, 2013
Phenyl salicylates - a new group of potential antituberculoticsKarel Waisser, Eva Novotná, Jiří Kuneš, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 6, 2022
Substituted N-phenylitaconamides as inhibitors of mycobacteria and mycobacterial isocitrate lyaseMartin Krátký, Eva Novotná, Jiřina Stolaříková, et al.
Infectious Disease Reports|November 22, 2022
Rapid Progression of COVID-19-Associated Fatal Capillary Leak SyndromeEva Novotná, Pavlína Filipová, Ivan Vonke, et al.
European Journal of Medicinal Chemistry|August 22, 2012
Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analoguesJán Kozic, Eva Novotná, Marie Volková, et al.
Archives of Toxicology|October 7, 2020
Selective inhibition of aldo-keto reductase 1C3: a novel mechanism involved in midostaurin and daunorubicin synergismAnselm Morell, Eva Novotná, Jaroslav Milan, et al.
Archives of Toxicology|June 27, 2020
Interactions of antileukemic drugs with daunorubicin reductases: could reductases affect the clinical efficacy of daunorubicin chemoregimens?Eva Novotná, Anselm Morell, Neslihan Büküm, et al.
Molecules (Basel, Switzerland)|March 27, 2013
Antibacterial activity of salicylanilide 4-(trifluoromethyl)-benzoatesMartin Krátký, Jarmila Vinšová, Eva Novotná, et al.
International Journal of Radiation Biology|February 1, 2013
DNA-dependent protein kinase and its inhibition in support of radiotherapyEva Novotná, Aleš Tichý, Jaroslav Pejchal, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Klinicka Mikrobiologie a Infekcni Lekarstvi|October 2, 2022
[Pneumothorax, pneumomediastinum and subcutaneous emphysema as complica-tions of COVID-19]Tereza Koníčková, František Puškáš, Eva Novotná, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 17, 2013
Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyaseMartin Krátký, Jarmila Vinšová, Eva Novotná, et al.
Ceska a Slovenska Farmacie : Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti|February 8, 2013
Phenyl salicylates - a new group of potential antituberculoticsKarel Waisser, Eva Novotná, Jiří Kuneš, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 6, 2022
Substituted N-phenylitaconamides as inhibitors of mycobacteria and mycobacterial isocitrate lyaseMartin Krátký, Eva Novotná, Jiřina Stolaříková, et al.
Infectious Disease Reports|November 22, 2022
Rapid Progression of COVID-19-Associated Fatal Capillary Leak SyndromeEva Novotná, Pavlína Filipová, Ivan Vonke, et al.
European Journal of Medicinal Chemistry|August 22, 2012
Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analoguesJán Kozic, Eva Novotná, Marie Volková, et al.
Archives of Toxicology|October 7, 2020
Selective inhibition of aldo-keto reductase 1C3: a novel mechanism involved in midostaurin and daunorubicin synergismAnselm Morell, Eva Novotná, Jaroslav Milan, et al.
Archives of Toxicology|June 27, 2020
Interactions of antileukemic drugs with daunorubicin reductases: could reductases affect the clinical efficacy of daunorubicin chemoregimens?Eva Novotná, Anselm Morell, Neslihan Büküm, et al.
Molecules (Basel, Switzerland)|March 27, 2013
Antibacterial activity of salicylanilide 4-(trifluoromethyl)-benzoatesMartin Krátký, Jarmila Vinšová, Eva Novotná, et al.
International Journal of Radiation Biology|February 1, 2013
DNA-dependent protein kinase and its inhibition in support of radiotherapyEva Novotná, Aleš Tichý, Jaroslav Pejchal, et al.
Pageof 4